Tom Snow: The FDA accepted for Priority Review Sanofi’s application for investigational therapy in multiple myeloma

Tom Snow, General Manager at US Oncology, Sanofi, shared a post on LinkedIn:

“Today, the FDA accepted for Priority Review Sanofi’s application for our investigational combination regimen in newly diagnosed Multiple Myeloma. This important milestone highlights a key step towards potentially addressing the unmet needs of people living with this blood cancer. Read on to learn more here.”

Source: Tom Snow/LinkedIn